These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The ability of prostate-specific antigen (PSA) density to predict an upgrade in Gleason score between initial prostate biopsy and prostatectomy diminishes with increasing tumour grade due to reduced PSA secretion per unit tumour volume. Corcoran NM, Casey RG, Hong MK, Pedersen J, Connolly S, Peters J, Harewood L, Gleave ME, Costello AJ, Hovens CM, Goldenberg SL. BJU Int; 2012 Jul; 110(1):36-42. PubMed ID: 22085203 [Abstract] [Full Text] [Related]
4. There is no way to identify patients who will harbor small volume, unilateral prostate cancer at final pathology. implications for focal therapies. Briganti A, Tutolo M, Suardi N, Gallina A, Abdollah F, Capitanio U, Freschi M, Bianchi M, Salonia A, Colombo R, Rigatti P, Montorsi F. Prostate; 2012 Jun 01; 72(8):925-30. PubMed ID: 21965006 [Abstract] [Full Text] [Related]
5. The role of transrectal saturation biopsy in tumour localization: pathological correlation after retropubic radical prostatectomy and implication for focal ablative therapy. Abdollah F, Scattoni V, Raber M, Roscigno M, Briganti A, Suardi N, Gallina A, Capitanio U, Freschi M, Salonia A, Cestari A, Guazzoni G, Rigatti P, Montorsi F. BJU Int; 2011 Aug 01; 108(3):366-71. PubMed ID: 21087451 [Abstract] [Full Text] [Related]
7. Prostate-specific antigen vs prostate-specific antigen density as a predictor of upgrading in men diagnosed with Gleason 6 prostate cancer by contemporary multicore prostate biopsy. Oh JJ, Hong SK, Lee JK, Lee BK, Lee S, Kwon OS, Byun SS, Lee SE. BJU Int; 2012 Dec 01; 110(11 Pt B):E494-9. PubMed ID: 22540236 [Abstract] [Full Text] [Related]
12. The relationship between tumor volume and the number of positive cores in men undergoing multisite extended biopsy: implication for expectant management. Ochiai A, Troncoso P, Chen ME, Lloreta J, Babaian RJ. J Urol; 2005 Dec 01; 174(6):2164-8, discussion 2168. PubMed ID: 16280756 [Abstract] [Full Text] [Related]
14. Biopsy core number represents one of foremost predictors of clinically significant gleason sum upgrading in patients with low-risk prostate cancer. Capitanio U, Karakiewicz PI, Valiquette L, Perrotte P, Jeldres C, Briganti A, Gallina A, Suardi N, Cestari A, Guazzoni G, Salonia A, Montorsi F. Urology; 2009 May 01; 73(5):1087-91. PubMed ID: 19195695 [Abstract] [Full Text] [Related]
19. Updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection: the essential importance of percentage of positive cores. Briganti A, Larcher A, Abdollah F, Capitanio U, Gallina A, Suardi N, Bianchi M, Sun M, Freschi M, Salonia A, Karakiewicz PI, Rigatti P, Montorsi F. Eur Urol; 2012 Mar 01; 61(3):480-7. PubMed ID: 22078338 [Abstract] [Full Text] [Related]